236 related articles for article (PubMed ID: 24708937)
21. Process intensification for cytochrome P450 BM3-catalyzed oxy-functionalization of dodecanoic acid.
Buergler MB; Dennig A; Nidetzky B
Biotechnol Bioeng; 2020 Aug; 117(8):2377-2388. PubMed ID: 32369187
[TBL] [Abstract][Full Text] [Related]
22. Crystallographic insights into a cobalt (III) sepulchrate based alternative cofactor system of P450 BM3 monooxygenase.
Panneerselvam S; Shehzad A; Mueller-Dieckmann J; Wilmanns M; Bocola M; Davari MD; Schwaneberg U
Biochim Biophys Acta Proteins Proteom; 2018 Jan; 1866(1):134-140. PubMed ID: 28739446
[TBL] [Abstract][Full Text] [Related]
23. Analysis of the oxidation of short chain alkynes by flavocytochrome P450 BM3.
Waltham TN; Girvan HM; Butler CF; Rigby SR; Dunford AJ; Holt RA; Munro AW
Metallomics; 2011 Apr; 3(4):369-78. PubMed ID: 21431175
[TBL] [Abstract][Full Text] [Related]
24. Hydroxylation of non-substituted polycyclic aromatic hydrocarbons by cytochrome P450 BM3 engineered by directed evolution.
Sideri A; Goyal A; Di Nardo G; Tsotsou GE; Gilardi G
J Inorg Biochem; 2013 Mar; 120():1-7. PubMed ID: 23262457
[TBL] [Abstract][Full Text] [Related]
25. DNA-mediated assembly of cytochrome P450 BM3 subdomains.
Erkelenz M; Kuo CH; Niemeyer CM
J Am Chem Soc; 2011 Oct; 133(40):16111-8. PubMed ID: 21919448
[TBL] [Abstract][Full Text] [Related]
26. Affinity isolation and characterization of cytochrome P450 102 (BM-3) from barbiturate-induced Bacillus megaterium.
Black SD; Linger MH; Freck LC; Kazemi S; Galbraith JA
Arch Biochem Biophys; 1994 Apr; 310(1):126-33. PubMed ID: 8161195
[TBL] [Abstract][Full Text] [Related]
27. Improving the activity of cytochrome P450 BM-3 catalyzing indole hydroxylation by directed evolution.
Pengpai Z; Sheng H; Lehe M; Yinlin L; Zhihua J; Guixiang H
Appl Biochem Biotechnol; 2013 Sep; 171(1):93-103. PubMed ID: 23817788
[TBL] [Abstract][Full Text] [Related]
28. Key mutations alter the cytochrome P450 BM3 conformational landscape and remove inherent substrate bias.
Butler CF; Peet C; Mason AE; Voice MW; Leys D; Munro AW
J Biol Chem; 2013 Aug; 288(35):25387-25399. PubMed ID: 23828198
[TBL] [Abstract][Full Text] [Related]
29. High throughput assay for cytochrome P450 BM3 for screening libraries of substrates and combinatorial mutants.
Tsotsou GE; Cass AE; Gilardi G
Biosens Bioelectron; 2002 Jan; 17(1-2):119-31. PubMed ID: 11742743
[TBL] [Abstract][Full Text] [Related]
30. Stereoselective hydroxylation of isophorone by variants of the cytochromes P450 CYP102A1 and CYP101A1.
Dezvarei S; Lee JHZ; Bell SG
Enzyme Microb Technol; 2018 Apr; 111():29-37. PubMed ID: 29421034
[TBL] [Abstract][Full Text] [Related]
31. Regio- and stereoselective hydroxylation of 10-undecenoic acid with a light-driven P450 BM3 biocatalyst yielding a valuable synthon for natural product synthesis.
Kato M; Nguyen D; Gonzalez M; Cortez A; Mullen SE; Cheruzel LE
Bioorg Med Chem; 2014 Oct; 22(20):5687-91. PubMed ID: 24938497
[TBL] [Abstract][Full Text] [Related]
32. Human P450-like oxidation of diverse proton pump inhibitor drugs by 'gatekeeper' mutants of flavocytochrome P450 BM3.
Butler CF; Peet C; McLean KJ; Baynham MT; Blankley RT; Fisher K; Rigby SE; Leys D; Voice MW; Munro AW
Biochem J; 2014 Jun; 460(2):247-59. PubMed ID: 24588219
[TBL] [Abstract][Full Text] [Related]
33. Engineering cytochrome P450 BM3 of Bacillus megaterium for terminal oxidation of palmitic acid.
Brühlmann F; Fourage L; Ullmann C; Haefliger OP; Jeckelmann N; Dubois C; Wahler D
J Biotechnol; 2014 Aug; 184():17-26. PubMed ID: 24833423
[TBL] [Abstract][Full Text] [Related]
34. Application of a fluorescence-based continuous-flow bioassay to screen for diversity of cytochrome P450 BM3 mutant libraries.
Reinen J; Ferman S; Vottero E; Vermeulen NP; Commandeur JN
J Biomol Screen; 2011 Feb; 16(2):239-50. PubMed ID: 21297109
[TBL] [Abstract][Full Text] [Related]
35. A rapid screening for cytochrome P450 catalysis on new chemical entities: cytochrome P450 BM3 and 1,2,5-oxadiazole derivatives.
Tsotsou GE; Di Nardo G; Sadeghi SJ; Fruttero R; Lazzarato L; Bertinaria M; Gilardi G
J Biomol Screen; 2013 Feb; 18(2):211-8. PubMed ID: 22983164
[TBL] [Abstract][Full Text] [Related]
36. Insights into electron leakage in the reaction cycle of cytochrome P450 BM3 revealed by kinetic modeling and mutagenesis.
Lim JB; Barker KA; Eller KA; Jiang L; Molina V; Saifee JF; Sikes HD
Protein Sci; 2015 Nov; 24(11):1874-83. PubMed ID: 26311413
[TBL] [Abstract][Full Text] [Related]
37. Control of the stereo-selectivity of styrene epoxidation by cytochrome P450 BM3 using structure-based mutagenesis.
Huang WC; Cullis PM; Raven EL; Roberts GC
Metallomics; 2011 Apr; 3(4):410-6. PubMed ID: 21240430
[TBL] [Abstract][Full Text] [Related]
38. Filling a hole in cytochrome P450 BM3 improves substrate binding and catalytic efficiency.
Huang WC; Westlake AC; Maréchal JD; Joyce MG; Moody PC; Roberts GC
J Mol Biol; 2007 Oct; 373(3):633-51. PubMed ID: 17868686
[TBL] [Abstract][Full Text] [Related]
39. Identification of mutant Asp251Gly/Gln307His of cytochrome P450 BM3 for the generation of metabolites of diclofenac, ibuprofen and tolbutamide.
Tsotsou GE; Sideri A; Goyal A; Di Nardo G; Gilardi G
Chemistry; 2012 Mar; 18(12):3582-8. PubMed ID: 22337118
[TBL] [Abstract][Full Text] [Related]
40. A tailor-made, self-sufficient and recyclable monooxygenase catalyst based on coimmobilized cytochrome P450 BM3 and glucose dehydrogenase.
Valikhani D; Bolivar JM; Dennig A; Nidetzky B
Biotechnol Bioeng; 2018 Oct; 115(10):2416-2425. PubMed ID: 30036448
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
